Short answer
ANGIODYNAMICS INC (ANGO) filed its Q4 2025 10-Q quarterly report on Jan 6, 2026 for the quarter ended Nov 30, 2025. Quarterly revenue was $79M (up 9.0% year over year) with net income of −$6M.
Q4 2025 key financials · XBRL
- Revenue
- $79M
- +9.0% YoY · +4.9% QoQ
- Net income
- −$6M
- +40.9% YoY · +41.8% QoQ
- Operating margin
- -7.7%
- Gross margin
- 56.4%
- EPS (diluted)
- −$0.16
- +40.7% YoY · +38.5% QoQ
Source: XBRL data from the ANGIODYNAMICS INC (ANGO) Q4 2025 10-Q on SEC EDGAR. USD.
ANGIODYNAMICS INC Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $79.4M, up 9.0% YoY from $72.8M
- Gross margin 56.4% vs 54.8% YoY
- Med Tech revenue $35.7M, up 13.0%; Med Device revenue $43.8M, up 6.0%
- Cash $41.6M vs $55.9M at May 31; operating cash use $11.3M vs $15.8M
- Outlook: liquidity sufficient for at least 12 months; headwinds from tariffs, inflation, labor shortages, and supply-chain challenges
Risk Factors
- No risk-factors section provided; supplied text covers equity repurchases, defaults, mine safety, insider trading, and exhibits
- No shares repurchased during the quarter
- $15.0 million remaining authorization under the July 16, 2024 repurchase program
- No senior-security defaults reported
- No directors or officers adopted or terminated Rule 10b5-1 arrangements during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ANGIODYNAMICS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.